We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News   Oct 16, 2019

 
Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

Product News

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

READ MORE

Promising Phase 2a Data on Prostate Cancer Immunotherapy

Product News

Vaccitech Limited and the University of Oxford have announced initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).

READ MORE

Collaborative To Assess Point-of-Care Manufacturing for Cancer Cell Therapies

Product News

Lonza has announced a series of collaborations with leading institutions to exhibit the proprietary Cocoon® Platform’s ability to manufacture novel cell therapies in a decentralized setting.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE